SEC Form 4 · accession 0001405626-16-000003
Q BioMed Inc. · QBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Denis Corin
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jul 15, 2016
Accepted (ET)
Dec 14, 2016 · 3:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001596062
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantF1 | $1.45 | Jul 15, 2016 | A | 37,500 | A | Jul 15, 2016 | Jul 15, 2021 | Common Stock | 37,500 | 2,537,500 | D |
| WarrantF1 | $1.45 | Jul 15, 2016 | A | 37,500 | A | Oct 15, 2016 | Jul 15, 2021 | Common Stock | 37,500 | 2,575,000 | D |
| WarrantF1 | $1.45 | Jul 15, 2016 | A | 37,500 | A | Jan 15, 2017 | Jul 15, 2021 | Common Stock | 37,500 | 2,612,500 | D |
| WarrantF1 | $1.45 | Jul 15, 2016 | A | 37,500 | A | Apr 15, 2017 | Jul 15, 2021 | Common Stock | 37,500 | 2,650,000 | D |
Explanation of responses
- F1Issued for director services.